Skip to main content

Table 2 Distribution of PSA level within each ISUP grade group (n = 189)

From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

  PSA (ng/mL)
 ≤ 10 10–20  > 20
ISUP grade (n = 189)    
1 3 (38%) 2 (25%) 3 (38%)
2 23 (56%) 12 (29%) 6 (15%)
3 26 (52%) 8 (16%) 16 (32%)
4 19 (56%) 9 (26%) 6 (18%)
5 29 (52%) 18 (32%) 9 (16%)
Unknowna 1 (20%) 1 (20%) 3 (60%)
  1. n(%) = number of patients (% of patients in ISUP grade group)
  2. aFive patients had missing ISUP grade information